A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UC San Francisco in collaboration with colleagues in Sweden. As a result, “ultralow” risk patients could be treated less aggressively and overtreatment avoided, leading to fewer toxic effects.

Asian-American women are more likely to experience delays in follow-up treatment after an abnormal mammogram compared to white women, according to new UC San Francisco research.

A goal of precision medicine for cancer is to match patients with the most appropriate treatments based on information about the genetic and molecular changes in their tumors. This approach can also help patients avoid treatments that would be unlikely to help and could cause harm.

Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.

In what is believed to be the first large-scale study to quantify the development of breast cancer according to the degree of glandular tissue versus fat, researchers headed by UC San Francisco evaluated risk factors in more than 200,000 women.

Karla Kerlikowske, MD, and team recently published a paper in the Journal of the National Cancer Institute that examined the role of common risk factors in the development of ER-positive and ER-negative breast cancers. The study sheds new light on how a woman's age, weight, ...